North America Cancer tissue diagnostics market is expected to reach US$ 4,350 million by 2027 with CAGR of 8%.

All News

North America Cancer tissue diagnostics market is poised to grow from close to US$ 4,350 Mn in 2016 to nearly US$ 9,650 Mn by 2026 end. This represents a CAGR of 8% over the forecast period. North America Cancer market for cancer tissue diagnostics represents incremental opportunity of about US$ 5,300 Mn between 2016 and 2026.

The growth of the market is driven by the factors such as, growing cancer prevalence in North American region and new product launches & FDA approvals. However, the market is likely to slower down its growth due to the lack of reimbursement policies for cancer diagnosis in the region.

US is expected to lead the cancer tissue diagnostics market in the North America region owing to increasing prevalence of cancer, improved diagnosis and treatment of the condition along with the advancements made by market players. Moreover, the country has several hospitals, super specialty hospitals which offers diagnostic and treatment services for the cardiovascular diseases. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.

The Business Market Insights subscription helps clients understand the ongoing market trends, identify opportunities, and make informed decisions through the reports in the Subscription Platform. The Industry reports available in the subscription provide an in-depth analysis on various market topics and enable clients to line up remunerative opportunities. The reports provide the market size & forecast, drivers, challenges, trends, and more.

Get free trial subscription and gain instant access to our market research reports at

Most of the major market players are involved in the manufacturing wide range of cancer diagnostics products that offer maximum advantages and early diagnosis. For instance, in June 2019, Agilent Technologies Inc. received the U.S. Food and Drug Administration (FDA) approval for its PD-L1 IHC 22C3 pharmDx assay. The assay is approved to aim in identifying patients with head and neck squamous cell carcinoma (HNSCC) for treatment with KEYTRUDA (pembrolizumab), anti-PD-1 therapy manufactured by Merck. Furthermore, In March 2018, Agilent Technologies Inc. launched a new color for immunohistochemistry: HRP Magenta for Dako Omnis.

Business Market Insights reports focus upon client objectives, use standard research methodologies and exclusive analytical models, combined with robust business acumen, which provides precise and insightful results.

Business Market Insights reports are useful not only for corporate and academic professionals but also for consulting, research firms, PEVC firms, and professional services firms.


By Test Type

Immunohistochemical Tests

Breast Cancer

Colorectal Cancer

Prostate Cancer

Stomach Cancer


In Situ Hybridization Tests

Breast Cancer

Lung Cancer

Bladder Cancer


Company Profiles

F. Hoffmann-La Roche Ltd

Thermo Fisher Scientific Inc.

Bio Rad Laboratories Inc.


Enzo Life Sciences, Inc.

Agilent Technologies, Inc.

Cancer Genetics Inc.

Merck KGaA (Sigma-Aldrich Co. LLC)

Danaher Corporation

Abcam plc

Full Report subscription with pay as per requirement at

(30-day subscription plans prove to be very cost-effective with no compromise on the quality of reports)

Benefits with Business Market Insights

  • One Stop Platform to All the Market Insight Needs
  • Avoid Long Purchase Procedures
  • Fast and Easy Access
  • Cloud-Based Platform
  • News Updates
  • Ask the Analyst Support
  • Pay Monthly Subscription and Access All You Want
  • No Compulsion for Yearly Subscription
  • Reports Read or Download Access
  • Monthly New Reports Added
  • Affordable Product, Pay as Per Requirement

About Business Market Insights

Based in New York, Business Market Insights is a one-stop destination for in-depth market research reports from various industries including Technology, Media & Telecommunications, Semiconductor & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Manufacturing and Construction   IT, Manufacturing & Construction, Medical Device, and Chemicals & Materials. The clients include corporate and academic professionals, consulting, research firms, PEVC firms, and professional services firms.

For Subscription contact

Business Market Insights

Phone : +442081254005
E-Mail : [email protected]